Evidence map›Paper›PMID 11549581›Full record

ArticleThe American journal of pathology2001

A definitive role of ornithine decarboxylase in photocarcinogenesis.

N Ahmad, A C Gilliam, S K Katiyar, T G O'Brien, H Mukhtar

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. [Chronic skin damage from UV radiation].Dermatologie (Heidelberg, Germany) · 2026
    Review
  3. Review
  4. Article
  5. Phytochemicals for the Prevention of Photocarcinogenesis.Photochemistry and photobiology · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Targeting polyamines and inflammation for cancer prevention.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2011
    Review
  15. Review
  16. Article
  17. Article
  18. Polyamines and nonmelanoma skin cancer.Toxicology and applied pharmacology · 2007
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

N AhmadDepartment of Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 44106, USA. nxa3@po.cwru.edu
A C Gilliam
S K Katiyar
T G O'Brien
H Mukhtar
Case Western Reserve University · USLankenau Institute for Medical Research · USUniversity Hospitals of Cleveland · US

Funding

Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
Green Tea in Chemoprevention of Prostate CancerR01CA078809 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MUKHTAR, HASAN · 1999 to 2008
$1.9M
CHEMOPREVENTION OF PROSTATE CANCER BY SANGUINARINER03CA089723 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI AHMAD, NIHAL · 2001 to 2002
$149k
MONOCYTE/ENDOTHELIAL INTERACTIONS--MONOCYTE ACTIVATIONR55AR045033 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI GILLIAM, ANITA C · 1998 to 1998
–
NCI NIH HHS R01 CA078809NCI NIH HHS R01 CA 78809NCI NIH HHS R03 CA-89723NIAMS NIH HHS P30 AR039750NIAMS NIH HHS P30 AR 39750NIAMS NIH HHS R03 AR45033PHS HHS R03 46423
6 · The paper itself

Abstract

Excessive exposure of solar ultraviolet (UV) radiation, particularly its UVB component, to human skin is the major cause for more than a million new cases of cutaneous malignancies diagnosed annually in the United States. Photocarcinogenesis, like other cancers, is a multistep process that includes initiation and promotion. A proper understanding of the molecular events occurring during the tumor promotion phase of photocarcinogenesis could lead to the development of novel approaches for the management of skin cancer. Using a transgenic mouse model (K5/ODC mice), which overexpresses the enzyme ornithine decarboxylase (ODC) in hair follicle keratinocytes, we studied the role of this gene in photocarcinogenesis. A single UVB-exposure of 180 mJ/cm(2) to the transgenic mice resulted in a minimal increase in bifold skin thickness and ODC activity. However, in SKH-1 hairless mice, the most common and highly sensitive model for photocarcinogenesis, and in littermate nontransgenic mice, increases in skin thickness and ODC activity were substantial. In long-term experiments, mice were exposed to 180 mJ/cm(2) of UVB radiation three times a week for 2 weeks (tumor-initiating dose). At 30 weeks after this treatment, in two independent experiments, 40% of the K5/ODC transgenic mice exposed to UVB were found to develop epidermal tumors. The tumors were histologically verified as benign papillomas and squamous cell carcinomas. Interestingly, 100% of the transgenic mice also developed >20 pigmented cysts/mouse, which contained keratinocyte material with increased keratinocytic melanization. Under similar UVB-exposure protocol, the nontransgenic littermates or SKH-1 hairless mice did not develop tumors or pigmented cysts for up to 50 weeks. Oral consumption of alpha-difluoromethylornithine, an irreversible specific inhibitor of ODC, in the drinking water (1% w/v) to the transgenic mice resulted in complete prevention of UVB-mediated tumorigenesis and a substantial decrease in the formation of pigmented cysts (<10 per mouse). These data establish a definitive role of ODC in the promotion phase of photocarcinogenesis.

Indexed as

Ultraviolet RaysAnimalsCystsMiceMice, HairlessMice, KnockoutNeoplasms, Radiation-InducedOrnithine DecarboxylaseSkinSkin DiseasesSkin NeoplasmsOrnithine Decarboxylase

Identifiers

PMID11549581
PMCPMC1850478
OpenAlexW1968415470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.